[HTML][HTML] TOLLIP protein expression predicts unfavorable outcome in renal cell carcinoma
A Kowalewski, D Jaworski, J Borowczak… - International Journal of …, 2022 - mdpi.com
Resistance to systemic therapy is one of the hallmarks of renal cell carcinoma (RCC).
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma
A Kowalewski, D Jaworski, J Borowczak, M Maniewski… - IJMS, 2022 - agris.fao.org
Resistance to systemic therapy is one of the hallmarks of renal cell carcinoma (RCC).
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma
A Kowalewski, D Jaworski, J Borowczak… - International …, 2022 - search.proquest.com
Resistance to systemic therapy is one of the hallmarks of renal cell carcinoma (RCC).
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma
A Kowalewski, D Jaworski… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Resistance to systemic therapy is one of the hallmarks of renal cell carcinoma (RCC).
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
[引用][C] TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma
A Kowalewski, D Jaworski, J Borowczak… - International Journal of …, 2022 - mostwiedzy.pl
TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma - Publikacja
- MOST Wiedzy Przejdź do wyszukiwarki Przejdź do treści Przejdź do pomocy Przejdź do …
- MOST Wiedzy Przejdź do wyszukiwarki Przejdź do treści Przejdź do pomocy Przejdź do …
[PDF][PDF] Smoli nska, M.; Ligmanowska, J.; Grzanka, D.; et al. TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma
A Kowalewski, D Jaworski, J Borowczak… - Int. J. Mol …, 2022 - researchgate.net
Resistance to systemic therapy is one of the hallmarks of renal cell carcinoma (RCC).
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
[HTML][HTML] TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma
A Kowalewski, D Jaworski, J Borowczak… - … Journal of Molecular …, 2022 - ncbi.nlm.nih.gov
Resistance to systemic therapy is one of the hallmarks of renal cell carcinoma (RCC).
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma
A Kowalewski, D Jaworski, J Borowczak… - … Journal of Molecular …, 2022 - europepmc.org
Resistance to systemic therapy is one of the hallmarks of renal cell carcinoma (RCC).
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma.
A Kowalewski, D Jaworski… - International …, 2022 - search.ebscohost.com
Resistance to systemic therapy is one of the hallmarks of renal cell carcinoma (RCC).
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma.
A Kowalewski, D Jaworski, J Borowczak… - … Journal of Molecular …, 2022 - europepmc.org
Resistance to systemic therapy is one of the hallmarks of renal cell carcinoma (RCC).
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …
Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We …